| 000 | 01393nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 384321 | ||
| 010 | _a9291680613 | ||
| 090 | _a384321 | ||
| 100 | _a20070531d1999 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aGuidelines for the risk assessment of new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA |
||
| 210 |
_aLuxembourg _cOffice for Official Publications of the European Communities _d1999 |
||
| 215 |
_a33 p. _d21 cm |
||
| 330 | _aForeword. Introduction. Chapter 1 - Basic principles for risk assessment. Chapter 2 - A conceptual framework for risk assessment. Chapter 3 - Quality of information for risk assessment. Chapter 4 - Headings for risk assessment. Technical annex A - Pharmacotoxicological evidence. Technical annex B - Psychological risk assessment (cognition, mood and mental functioning). Technical annex C - Sociological/criminological evidence. Technical annex D - Public health risks: epidemiological evidence. | ||
| 606 |
_aDROGA SINTÉTICA _9320915 |
||
| 606 |
_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892 |
||
| 606 |
_aMETODOLOGIAS _9341295 |
||
| 606 |
_aOEDT _9321506 |
||
| 606 |
_aEMCDDA _9324041 |
||
| 710 |
_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987 |
||
| 955 | _xOferta | ||